Satoshi Kawano

Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in <i>EZH2</i> -Mutant Non-Hodgkin Lymphoma

Sarah K. Knutson, Satoshi Kawano, Yukinori Minoshima et al. · Molecular Cancer Therapeutics · 2014 · 522 citations

Medicine, Oncology, Pharmacology +14

Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models

Yasuhiro Funahashi, Kiyoshi Okamoto, Yusuke Adachi et al. · Cancer Science · 2014 · 278 citations · Full text

Medicine, Oncology, Pharmacology +17

EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity

John E. Campbell, Kevin W. Kuntz, Sarah K. Knutson et al. · ACS Medicinal Chemistry Letters · 2015 · 129 citations · Full text

Medicine, Oncology, Pharmacology +11

Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma

Satoshi Kawano, Alexandra Grassian, Masumi Tsuda et al. · PLoS ONE · 2016 · 76 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Room temperature epitaxial growth of m-plane GaN on lattice-matched ZnO substrates

Atsushi Kobayashi, Satoshi Kawano, Yuji Kawaguchi et al. · Applied Physics Letters · 2007 · 73 citations · Full text

Engineering, Materials Engineering, Materials Science +17